Resmed Inc. buy CLSA
Start price
02.09.25
/
50%
€232.70
Target price
02.09.26
-
Performance (%)
-16.14%
Price
10.04.26
€195.15
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.14%. This prediction currently runs until 02.09.26. The prediction end date can be changed by CLSA at any time. CLSA has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.412% | 0.412% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by CLSA for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at CLSA from a "hold" rating to an "outperform" rating.
Ratings data for RMD provided by MarketBeat